Pediatric Neuro-Oncology Tumor Board - 9/23/2024

---

RSS

Monday, September 23, 2024, 4:00 PM - 5:00 PM, MD Anderson - Virtual


AMA PRA Category 1 Credits™ (1.00 hours), AAPA Category 1 CME (1.00 hours), ABS CC (1.00 hours), ANCC - Nursing Contact Hour(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

This pediatric neuro-oncology tumor board will provide a forum for a multidisciplinary team of specialists to discuss the diagnosis and treatment of brain tumors in children. This series will collaboratively reviews each patient’s case to develop personalized treatment plans, integrating surgery, chemotherapy, radiation therapy, and supportive care. Their coordinated approach ensures comprehensive care and access to the latest clinical trials and research advancements.

Objective(s): 1 Implement the latest developments in imaging, surgical techniques, pathological diagnosis, and treatment protocols. 2 Assess the benefits of continuous learning and skill development to enhance individual and team professional growth, thus contributing to the overall success of the medical team. 3 Adopt a compassionate, appropriate, well-rounded, integrative, and interdisciplinary approach to patient care. 4 Focus on achieving the best possible outcomes for patients through collaborative decision-making and tailored treatment plans. 5 Effectively manage and coordinate the care of patients referred locally, nationally, and internationally.
Location: MD Anderson - Virtual
Specialties: Pathology, Pediatric Neurology, Surgery

Faculty Disclosures:
Diana S Osorio, MD, MPH (Nothing to disclose - 09/05/2024)
Download Handout

1. Implement the latest developments in imaging, surgical techniques, pathological diagnosis, and treatment protocols.
2. Assess the benefits of continuous learning and skill development to enhance individual and team professional growth, thus contributing to the overall success of the medical team.
3. Adopt a compassionate, appropriate, well-rounded, integrative, and interdisciplinary approach to patient care.
4. Focus on achieving the best possible outcomes for patients through collaborative decision-making and tailored treatment plans.
5. Effectively manage and coordinate the care of patients referred locally, nationally, and internationally.

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.